Provided by Tiger Trade Technology Pte. Ltd.

LeMaitre Vascular

80.24
-0.5300-0.66%
Pre-market: 80.01-0.2300-0.29%07:23 EDT
Volume:303.22K
Turnover:24.34M
Market Cap:1.83B
PE:28.08
High:80.85
Open:80.64
Low:79.36
Close:80.77
52wk High:118.01
52wk Low:78.27
Shares:22.85M
Float Shares:21.27M
Volume Ratio:1.12
T/O Rate:1.43%
Dividend:0.94
Dividend Rate:1.18%
EPS(TTM):2.86
EPS(LYR):2.52
ROE:16.77%
ROA:7.44%
PB:4.36
PE(LYR):31.84

Loading ...

LeMaitre Vascular Signals Profitable Growth Despite Headwinds

TIPRANKS
·
Aug 11

LeMaitre Vascular (LMAT) Has A Fresh Update, So Why Is It Drawing Attention?

Simply Wall St.
·
Aug 10

LeMaitre Vascular to Join Needham Virtual MedTech & Diagnostics 1x1 Conference

Reuters
·
Aug 07

Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95

MT Newswires Live
·
Aug 06

LeMaitre Vascular, Inc. : Barrington Research Raises to Outperform from Market Perform

THOMSON REUTERS
·
Aug 06

Teleflex Q2 Revenue Rises 29%, Beats Analyst Estimates

Reuters
·
Aug 06

LeMaitre Vascular Down over 22%, on Track for Largest Percent Decrease Since October 2008

Dow Jones
·
Aug 06

LeMaitre Vascular is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 05

Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform

MT Newswires Live
·
Aug 05

LeMaitre Vascular, Inc. : Barrington Research Cuts to Market Perform from Outperform

THOMSON REUTERS
·
Aug 05

LeMaitre downgraded to Market Perform from Outperform at Barrington

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Lemaitre Vascular (LMAT) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Aug 05

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

LeMaitre Vascular, Inc. : Jefferies Cuts Target Price to $100 from $110

THOMSON REUTERS
·
Aug 05

GUIDANCE: (LMAT) LeMaitre Vascular Expects 2026 Revenue Range $274.3 Million - $278.3 Million, vs. FactSet Est of $280 Million

MT Newswires Live
·
Aug 05

LeMaitre Vascular Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

LeMaitre Vascular Q2 FY26 EPS Rises 23% to $0.74; Net Sales Increase 10% to $70.4 Million

Reuters
·
Aug 05

LeMaitre Vascular Q2 EPS $0.74 Misses $0.79 Estimate, Sales $70.382M Miss $70.973M Estimate

Benzinga Earnings
·
Aug 05

LeMaitre Vascular Q2 Sales USD 70.382 Million Vs. IBES Estimate USD 71 Million

Reuters
·
Aug 05

LeMaitre Vascular Outlook Q3 Gross Margin 72.2%

THOMSON REUTERS
·
Aug 05